Related Subjects:
|Ulcerative Colitis
|Microscopic colitis
|Irritable bowel syndrome
|Lower Gastrointestinal (Rectal) Bleeding
πΏ Irritable Bowel Syndrome (IBS) is a chronic relapsing functional gut disorder.
β οΈ Not life-threatening, but can severely impact quality of life and work.
π‘ Management requires empathy, reassurance, and symptom control.
π About
- Common functional GI disorder with abdominal pain, bloating, and altered bowel habits.
- No structural pathology: normal endoscopy, no raised CRP/ESR, normal colonoscopy.
- Often overlaps with anxiety, depression, and other functional disorders (e.g., fibromyalgia).
- Healthcare burden: major cause of GP visits & work absenteeism.
𧬠Aetiology
- Abnormal brainβgut axis: altered motility, visceral hypersensitivity, stress responses.
- Triggered by psychosocial factors, gut microbiota changes, post-infectious states.
- βοΈ More common in women; frequency declines with age.
- Higher prevalence in those with psychiatric comorbidity (anxiety, depression, somatisation).
π©Ί Clinical Presentation
- Symptoms for β₯6 months.
- π Abdominal pain β often relieved by defecation.
- π© Altered bowel habit:
β IBS-D (diarrhoea predominant)
β IBS-C (constipation predominant)
β IBS-M (mixed, alternating)
- Other features:
β Incomplete evacuation
β Passage of mucus
β Bloating, nausea, dyspepsia
β Globus sensation, atypical chest pain (extracolonic symptoms)
π Rome IV Diagnostic Criteria
- Recurrent abdominal pain, on average β₯1 day/week in the last 3 months, associated with β₯2 of:
β Related to defecation
β Associated with change in stool frequency
β Associated with change in stool form (appearance)
- Onset β₯6 months before diagnosis.
π‘ Supportive Symptoms
- Abnormal stool frequency (>3/day or <3/week).
- Abnormal stool consistency (hard/lumpy or loose/watery).
- Straining, urgency, incomplete evacuation.
- Mucus passage.
- Abdominal distension or bloating.
π© Red Flags (Not IBS β urgent investigation)
- Unintentional weight loss.
- Rectal bleeding.
- Anaemia (iron deficiency).
- Nocturnal symptoms (waking from sleep).
- Onset >50 years.
- Family history: colorectal cancer, IBD, coeliac disease.
π Investigations
- Diagnosis = clinical (Rome IV) + exclusion of red flags.
- Basic screening tests:
β FBC (anaemia)
β CRP/ESR (inflammation)
β Coeliac serology (anti-tTG/EMA)
β TFTs, U&E, LFTs as appropriate
- Colonoscopy/sigmoidoscopy if alarm features.
- OGD if upper GI symptoms.
βοΈ Management
- π§ββοΈ Education & reassurance: IBS is benign but chronic. Emphasise lifestyle, stress management.
- π₯ Dietary strategies:
β Soluble fibre for IBS-C (avoid insoluble bran).
β Low FODMAP diet: reduces bloating & pain.
β Avoid caffeine, alcohol, spicy/fatty foods, carbonated drinks.
- π Medications:
β Antispasmodics (Mebeverine, Buscopan) β pain/cramps.
β Loperamide β IBS-D (caution: constipation).
β Osmotic laxatives (PEG, lactulose) β IBS-C (avoid stimulants).
β TCAs (e.g., Amitriptyline low dose) β IBS-D, visceral pain.
β SSRIs sometimes for IBS-C.
- π§ Psychological support:
β CBT (evidence-based for IBS).
β Relaxation therapy, mindfulness, hypnotherapy.
β Address comorbid anxiety/depression.
π‘ Teaching Pearls:
β IBS = functional disorder, no structural abnormality.
β Rome IV is diagnostic backbone.
β Red flags always prompt colonoscopy.
β Management = stepwise β reassurance β diet β drugs β psychological support.
β Be empathetic: quality of life impact is often underestimated.
Cases β Irritable Bowel Syndrome (IBS)
- Case 1 (IBS-D, diarrhoea-predominant): π©
A 29-year-old woman presents with a 2-year history of recurrent abdominal cramps, bloating, and loose stools up to 5 times/day, often after meals. Symptoms improve after defecation. No weight loss, rectal bleeding, or nocturnal symptoms. Blood tests (FBC, CRP, coeliac serology) are normal. Management: Diagnosis made using Rome IV criteria after exclusion of red-flag features. Started on dietary modification (low FODMAP diet), soluble fibre, and loperamide as required. Outcome: Stool frequency and bloating improve significantly with dietary measures and as-needed medication.
- Case 2 (IBS-C, constipation-predominant): π½
A 34-year-old man reports recurrent abdominal discomfort, bloating, and infrequent bowel movements (every 4β5 days), associated with straining and incomplete evacuation. No alarm features. Colonoscopy performed previously was normal. Management: Lifestyle advice (hydration, exercise, fibre), osmotic laxative (macrogol), and linaclotide trial when constipation persisted. Stress management discussed. Outcome: Bowel frequency improves to every 1β2 days with softer stools; abdominal pain reduced. Patient continues long-term dietary modifications and stress reduction.
- Case 3 (IBS-M, mixed type): π
A 41-year-old woman complains of alternating constipation and diarrhoea, with abdominal pain that worsens before defecation and improves afterwards. She notes symptoms worsen during stressful periods at work. Weight stable, no bleeding. Bloods, CRP, and coeliac screen normal. Management: Education and reassurance. Trial of a low FODMAP diet and peppermint oil capsules. Cognitive behavioural therapy (CBT) offered for stress-related flares. Outcome: Pain and bloating improve with diet and stress management. Maintains food/symptom diary; avoids unnecessary colonoscopies.
π§ββοΈ Teaching Commentary
IBS is a functional gastrointestinal disorder diagnosed clinically using Rome IV criteria.
Subtypes include:
β’ IBS-D (diarrhoea) π©
β’ IBS-C (constipation) π½
β’ IBS-M (mixed) π
Red-flag features π© (weight loss, bleeding, nocturnal symptoms, anaemia, family history of CRC/IBD) always warrant further investigation.
Management = reassurance, education, dietary modification (low FODMAP, fibre adjustment), stress reduction, and targeted drug therapy (loperamide, laxatives, linaclotide, peppermint oil, CBT). Prognosis is benign but symptoms can be chronic and relapsing.